Immunotherapy

Hi, does anyone have any info about when immunotherapy treatment comes to an end after two years? If the response has been good (ie it has been classed as terminal but scan shows "no change"; can it be offered again, and if not, why not and what are the options? I understand ever case is different but interested to hear others experiences of this and would appreciate any advice. Thank you. 

Parents
  • I have had 35 cycles of pembrolizumab finishing in November 2018. I was not allowed to continue after that on a clinical trial even though it was allowed for in the trial protocol, If you click on my posting history you will see the details.

    The short answer is, nobody knows what the optimum number of cycles are. Merck for example, the manufacture of pembrolizumab 'recommend' a maxamimun number of 24, this ties in with keeping it cost effective for the NHS. However, they still have people from their fisrt clinical trial still taking it 8 years later.

Reply
  • I have had 35 cycles of pembrolizumab finishing in November 2018. I was not allowed to continue after that on a clinical trial even though it was allowed for in the trial protocol, If you click on my posting history you will see the details.

    The short answer is, nobody knows what the optimum number of cycles are. Merck for example, the manufacture of pembrolizumab 'recommend' a maxamimun number of 24, this ties in with keeping it cost effective for the NHS. However, they still have people from their fisrt clinical trial still taking it 8 years later.

Children
No Data